These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5894 related items for PubMed ID: 3936214

  • 1. Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.
    Browne MJ, Dodd I, Carey JE, Chapman CG, Robinson JH.
    Thromb Haemost; 1985 Aug 30; 54(2):422-4. PubMed ID: 3936214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.
    Dodd I, Nunn B, Robinson JH.
    Thromb Haemost; 1988 Jun 16; 59(3):523-8. PubMed ID: 3142086
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
    Huisman LG, van Griensven JM, Kluft C.
    Thromb Haemost; 1995 Mar 16; 73(3):466-71. PubMed ID: 7667830
    [Abstract] [Full Text] [Related]

  • 13. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
    Camani C, Gavin O, Kruithof EK.
    Thromb Haemost; 2000 Feb 16; 83(2):290-6. PubMed ID: 10739388
    [Abstract] [Full Text] [Related]

  • 14. Cultivation of Bowes melanoma cells in the Opticell system: influence of the addition of protein supplements to the serum-free medium on the production of plasminogen activator.
    Bödeker BG, Klimetzek V, Klein U, Hewlett G, Schlumberger HD.
    Dev Biol Stand; 1987 Feb 16; 66():291-7. PubMed ID: 3108052
    [Abstract] [Full Text] [Related]

  • 15. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
    Kassam G, Le BH, Choi KS, Kang HM, Fitzpatrick SL, Louie P, Waisman DM.
    Biochemistry; 1998 Dec 01; 37(48):16958-66. PubMed ID: 9836589
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K, Ryuto M, Ushiro S, Ono M, Sugenoya A, Kuraoka A, Shibata Y, Kuwano M.
    J Cell Physiol; 1995 Feb 01; 162(2):213-24. PubMed ID: 7822431
    [Abstract] [Full Text] [Related]

  • 19. Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells.
    Larsson P, Ulfhammer E, Karlsson L, Bokarewa M, Wåhlander K, Jern S.
    Thromb Res; 2008 Feb 01; 123(2):342-51. PubMed ID: 18502475
    [Abstract] [Full Text] [Related]

  • 20. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
    Collen D, Stassen JM, Marafino BJ, Builder S, De Cock F, Ogez J, Tajiri D, Pennica D, Bennett WF, Salwa J.
    J Pharmacol Exp Ther; 1984 Oct 01; 231(1):146-52. PubMed ID: 6541693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 295.